Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hisashi Matsuki is active.

Publication


Featured researches published by Hisashi Matsuki.


Cancer Letters | 1989

Promoting effect of 2,4-diaminoanisole sulfate on rat thyroid carcinogenesis

Yoshiteru Kitahori; Masato Ohshima; Hisashi Matsuki; Noboru Konishi; Hiroyuki Hashimoto; Shigenori Minami; Witaya Thamavit; Yoshio Hiasa

Two experiments were conducted to examine the effects of 2,4-diaminoanisole sulfate (2,4-DAAS) on thyroid function and carcinogenesis in male Wistar rats. In experiment 1, feeding with 2,4-DAAS resulted in significantly elevated levels of thyroid stimulating hormone (TSH), reduced thyroxine (T4) and triiodothyronine (T3) in the serum, although the latter had almost recovered to normal levels by week 6. However, skin application did not affect serum levels. In experiment 2, administration of 0.5% 2,4-DAAS in the diet for 19 weeks, a week after a single 210 mg/100 g body weight i.p. injection of N-bis(2-hydroxypropyl)nitrosamine (DHPN), significantly increased the incidence and numbers of preneoplastic lesions (focal hyperplasia), adenomas and carcinomas developing in the thyroid gland. Histologically, brown pigment was usually observed within follicular epithelial cells in non-tumorous regions, but not in the tumors themselves.


Urological Research | 1987

Effects of single chemotherapeutic agents on development of urinary bladder tumor induced by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) in rats

Katsuhiro Babaya; S. Takahashi; Hitoshi Momose; Hisashi Matsuki; K. Sasaki; Shoji Samma; Seiichiro Ozono; Yoshihiko Hirao; Eijiro Okajima

SummaryChemotherapeutic agents were evaluated for effect on the development of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) in male Wistar strain rats. Seven hundred and two rats were given 0.05% BBN in drinking water for 8 weeks. After BBN treatment, the animals were divided into 26 groups to follow regimens of single chemotherapy. All drugs were administered intraperitoneally except in one group that was treated orally. In our experimental series, 5-fluorouracil (5-FU), N-(2-tetrahydrofuryl)-5-fluorouracil (FT-207), carbazilquinone (CQ), vincristine (VCR) and cis-diamminedichloroplatinum (CDDP) were effective in inhibiting the incidence of bladder tumor, however, adriamycin (ADM), mitomycin C (MMC), neocarsinostatin (NCS), cyclophosphamide (CPM) and bleomycin (BLM) were not effective.


Urologia Internationalis | 1991

Neoadjuvant Therapy for Locally Invasive Bladder Cancer: Results of Randomized Trials in 40 Patients

Seiichirou Ozono; Y. Kawata; Yoshinao Fukui; Kiyohide Fujimoto; Akio Iwai; Hisashi Matsuki; Shoji Samma; Yoshihiko Hirao; Eijiro Okajima

The present investigation was conducted to examine the effect of a neoadjuvant cyclophosphamide, doxorubicin and cisplatin (CAP) regimen with radiotherapy for locally invasive bladder cancer as a well-controlled randomized trial. Since 1986, a total of 40 patients with primary transitional cell carcinoma of the urinary bladder have been randomized into two groups: neoadjuvant CAP plus radiation-treated group and control group. Of 18 patients who received neoadjuvant chemotherapy, complete and partial responses were observed in 52.9% of 17 measurable and evaluable patients and downstaging was observed in 92.9% of 14 evaluable patients. The 3-year survival rates of the neoadjuvant-treated and control group were 93.8 and 83.6%, respectively. No statistical significance was achieved in the survival rates. These results indicated that neoadjuvant CAP would be useful in the management of invasive bladder cancer.


Cancer Letters | 1988

Effects of trisodium nitrilotriacetate monohydrate, nitrilotriacetic acid and ammonium chloride on urinary bladder carcinogenesis in rats pretreated with N-bis(2-hydroxypropyl) nitrosamine

Yoshiteru Kitahori; Taketo Shimoyama; Masato Ohshima; Hisashi Matsuki; Hiroyuki Hashimoto; Shigenori Minami; Noboru Konishi; Yoshio Hiasa

The effects of trisodium nitrilotriacetate monohydrate (Na3 NTA.H2O) nitrilotriacetic acid (H3NTA) and ammonium chloride (NH4Cl) on two-stage urinary bladder carcinogenesis were examined. Carcinogenesis was initiated by administration of 0.2% N-bis (2-hydroxypropyl)-nitrosamine (DHPN) to male Wistar rats in the drinking water for 2 weeks, and then the animals were treated with basal diet containing Na3NTA.H2O, Na3NTA.H2O plus NH4Cl, H3NTA, H3NTA plus NH4Cl, or without these chemicals for 28 weeks. Na3NTA.H2O increased significantly the resultant incidence of neoplastic and preneoplastic lesions of the urinary bladder. Moreover, treatment with Na3NTA.H2O, without the initiation, itself induced papillary or nodular (PN)-hyperplasia. H3NTA produced only a slight increase in the incidence of preneoplastic urinary bladder lesions (PN-hyperplasia) in rats initiated by DHPN, and this was not statistically significant. Elevation of both pH and sodium ion concentration in the urine were correlated with promotion of tumor development. These data showed that Na3NTA.H2O was more effective than H3NTA with regard to promoting potential, and that changes in both urinary pH and concentration of sodium played important roles in enhancement of urinary bladder tumorigenesis by these chemicals.


GANN Japanese Journal of Cancer Research | 1984

RAPID INDUCTION OF CARCINOMA IN SITU IN DOG URINARY BLADDER BY SEQUENTIAL TREATMENT WITH N-METHYL-N'-NITROSOUREA AND N-BUTYL-N-(4-HYDROXYBUTYL)-NITROSAMINE

Shoji Samma; Hirotsugu Uemura; Shoichi Tabata; Akio Iwai; Fumiyoshi Nakatsuji; Hisashi Matsuki; Katsuhiro Babaya; Yoshihiko Hirao; Eigoro Okajima


Journal of Toxicologic Pathology | 1992

EFFECTS OF COMBINATION CHEMOTHERAPY INCLUDING CYCLOPHOSPHAMIDE, THP-ADRIAMYCIN, AND CISPLATIN ON THE DEVELOPMENT OF URINARY BLADDER CARCINOMA INDUCED BY N-BUTYL-N-(4-HYDROXYBUTYL) NITROSAMINE IN RATS

Yoshiki Hayashi; Seiichiro Ozono; Hisako Yamaguchi; Hisayo Kitagawa; Kunihiko Tsunemi; Shoichi Tabata; Hisashi Matsuki; Shoji Samma; Yoshihiko Hirao; Okajima E


Journal of Toxicologic Pathology | 1991

INDUCTION OF NEPHROSIS BY β-CYCLODEXTRIN IN BEAGLES

Shoichi Tabata; Seiichiro Ozono; Hisako Yamaguchi; Hisayo Kitagawa; Hirotsugu Uemura; Hisashi Matsuki; Shoji Samma; Yoshihiko Hirao; Eigoro Okajima; Yoshiteru Kitahori; Yoshio Hiasa


The Japanese Journal of Urology | 2004

Metachronous bilateral ureteral cancer in patient with hereditaly nonpolyposis colorectal cancer

Yamamoto M; Hiroki Kashiwai; Naoya Hirata; Hisashi Matsuki; Kazuhiro Shimizu; Nobumichi Tanaka; Seiichiro Ozono


Journal of Toxicologic Pathology | 1988

LACK OF CARCINOGENICITY OF COMMERCIAL SAFFLOWER YELLOW IN FISCHER 344 RATS

Hisashi Matsuki; Yoshiteru Kitahori; Shigenori Minami; Hiroyuki Hashimoto; Yasuhiro Sakaguchi; Masato Ohshima; Yoshio Hiasa


Journal of Toxicologic Pathology | 1996

INHIBTORY EFFECTS OF COMBINATION CHEMOTHERAPEUTIC REGIMENS ON MOUSE BLADDER CARCINOGENESIS INDUCED BY N-BUTYL-N-(4-HYDROXYBUTYL) NITROSAMINE

Seiichiro Ozono; Hisako Yamaguchi; Hisashi Matsuki; Tatsuo Yoneda; Kenji Takashima; Yoshiki Hayashi; Yoshikawa M; Hisayo Kitagawa; Yoshihiko Hirao; Eigoro Okajima

Collaboration


Dive into the Hisashi Matsuki's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shoji Samma

National Archives and Records Administration

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yoshio Hiasa

Nara Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge